0001214659-20-004967.txt : 20200522
0001214659-20-004967.hdr.sgml : 20200522
20200522210722
ACCESSION NUMBER: 0001214659-20-004967
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200520
FILED AS OF DATE: 20200522
DATE AS OF CHANGE: 20200522
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Leproust Emily M.
CENTRAL INDEX KEY: 0001753655
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38720
FILM NUMBER: 20907766
MAIL ADDRESS:
STREET 1: C/O TWIST BIOSCIENCE CORPORATION
STREET 2: 455 MISSION BAY BOULEVARD SOUTH
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Twist Bioscience Corp
CENTRAL INDEX KEY: 0001581280
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 462058888
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 681 GATEWAY BLVD.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 800-719-0671
MAIL ADDRESS:
STREET 1: 681 GATEWAY BLVD.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
marketforms-48847.xml
PRIMARY DOCUMENT
X0306
4
2020-05-20
0001581280
Twist Bioscience Corp
TWST
0001753655
Leproust Emily M.
C/O TWIST BIOSCIENCE CORPORATION
681 GATEWAY BLVD.
SOUTH SAN FRANCISCO
CA
94080
true
true
false
false
President & CEO
Common Stock
2020-05-20
4
S
false
29045
39.5385
D
817017
D
Common Stock
2020-05-20
4
S
false
11311
40.2063
D
805706
D
Common Stock
2020-05-20
4
S
false
600
41.07
D
805106
D
Common Stock
2020-05-20
4
F
false
3007
39.76
D
802099
D
Common Stock
2020-05-21
4
S
false
500
37.7775
D
801599
D
Common Stock
2020-05-21
4
S
false
5700
39.1706
D
795899
D
Common Stock
2020-05-21
4
S
false
8238
39.8994
D
787661
D
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
Represents the weighted average sales price per share. The shares sold at prices ranging from $38.90 to $39.89 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
Includes shares that were acquired under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
Represents the weighted average sales price per share. The shares sold at prices ranging from $39.90 to $40.85 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e).
Represents the weighted average sales price per share. The shares sold at prices ranging from $37.51 to $38.11 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
Represents the weighted average sales price per share. The shares sold at prices ranging from $38.52 to $39.50 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
Represents the weighted average sales price per share. The shares sold at prices ranging from $39.52 to $40.18 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
/s/ William Solis, as Attorney-in-Fact for Emily M. Leproust
2020-05-22